Cardiac Science Inc.:
The Irvine developer of external cardiac defibrillator devices and software said its losses for the second quarter grew to $2.8 million, or 23 cents a share, from $1.9 million, or 24 cents a share, a year earlier, on fewer shares of stock outstanding. Revenue totaled $925,000, compared with no revenue for the second quarter last year.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
